Resilience Biotechnologies News and Activities
Presence
Resilience Biotechnologies develops and manufactures medicines for biotechnology and pharmaceutical companies. Its services include process development, manufacturing, and supply support for complex biologic and advanced therapy products.
Resilience Biotechnologies products and services overview:
- Biologics manufacturing
- Cell therapy
- Gene therapy
- Process development
- Analytical testing
- Supply chain services
Revenue: ~$200 million
Employees: 1,200
Headquarters: San Diego, United States (USA)
Resilience Biotechnologies is one of the...
Executives
View the org chart displaying its 22 main executives
Most searched biographies at Resilience Biotechnologies
Create your alert
to follow the executive moves at Resilience Biotechnologies.
Biotechnology
Resilience Biotechnologies has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Resilience Biotechnologies
- Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
- Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash
- Resilience is proud to support CARGO Therapeutics' novel allogeneic CAR-T cell therapy
- Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD
- Resilience Announces Appointment of William S. Marth, RPh., MBA as Chief Executive Officer
- News - blog : Resilience
- News - blog : Resilience
- Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients
- Resilience Appoints Dr. Susan Billings, Chief Commercial Officer
- Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine | Business Wire
- View more press releases Close
Social media about Resilience Biotechnologies
- Resilience Biotechnologies on Wikipedia, Google News & Yahoo Finance
- Resilience Biotechnologies on LinkedIn, X (Twitter) & YouTube
